ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $628,707 | -33.4% | 97,323 | -22.3% | 0.00% | -40.0% |
Q1 2023 | $944,340 | -54.9% | 125,244 | -36.2% | 0.01% | -54.5% |
Q2 2022 | $2,092,000 | +65.2% | 196,406 | +51.2% | 0.01% | +57.1% |
Q1 2022 | $1,266,000 | -67.0% | 129,882 | -25.5% | 0.01% | -74.1% |
Q2 2021 | $3,837,000 | – | 174,428 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |